Chain Biotech Ltd

CHAIN Biotechnology Ltd was founded by Dr Edward Green in 2014 to develop new Clostridium-based microbial technology for high value healthcare products. CHAIN produces novel live biotherapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD).

At the heart of CHAIN’s unique therapeutic platform is a suite of underpinning technologies including a Clostridia culture collection, a proprietary set of plasmid vectors, synthetic biology tools for advanced metabolic engineering, and an advanced in-vivo delivery mechanism using Clostridium.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

CHAIN Features in Engineering Biology Explained

CHAIN features in a new explainer document on engineering biology from the UK Bioindustry...

read more

CHAIN at Microbiome Conferences in June

CHAIN Chief Executive Dr Edward Green will be speaking at the 2nd Annual Microbiome...

read more

CHAIN to Explore Manufacturing of Novel Medicines

UK biotech to manufacture novel medicines for Inflammatory Bowel Disease using spores of gut...

read more

CHAIN Awarded Two Grants to Develop High-Value Products

CHAIN has been awarded £0.5M grant funding from Innovate UK, the UK’s Innovation agency,...

read more

CHAIN at Microbiome & Biotech Conferences in 2018

CHAIN plans to attend a record number of microbiome and biotech conferences over the...

read more

CHAIN’s Website Redesign & Online Store

CHAIN are excited to announce the launch of our re-designed website. The new look...

read more

More Companies in Medical / Biotechnology